Annual EBITDA
-$8.08 M
+$130.85 M+94.18%
December 31, 2022
Summary
- As of February 10, 2025, ORTX annual EBITDA is -$8.08 million, with the most recent change of +$130.85 million (+94.18%) on December 31, 2022.
- During the last 3 years, ORTX annual EBITDA has risen by +$154.37 million (+95.03%).
Performance
ORTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$32.76 M
-$22.11 M-207.54%
September 30, 2023
Summary
- As of February 10, 2025, ORTX quarterly EBITDA is -$32.76 million, with the most recent change of -$22.11 million (-207.54%) on September 30, 2023.
- Over the past year, ORTX quarterly EBITDA has increased by +$14.44 million (+30.59%).
Performance
ORTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$66.59 M
+$14.44 M+17.82%
September 30, 2023
Summary
- As of February 10, 2025, ORTX TTM EBITDA is -$66.59 million, with the most recent change of +$14.44 million (+17.82%) on September 30, 2023.
- Over the past year, ORTX TTM EBITDA has increased by +$108.13 million (+61.89%).
Performance
ORTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ORTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +94.2% | +30.6% | +61.9% |
| 3 y3 years | +95.0% | -65.6% | +58.4% |
| 5 y5 years | +78.9% | +0.1% | +59.0% |
ORTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1619.7% | +345.2% | +52.0% | at high | +162.4% |
| 5 y | 5-year | at high | +1910.8% | +345.2% | +52.0% | at high | +174.0% |
| alltime | all time | at high | +2794.3% | +345.2% | +376.0% | +390.7% | +272.9% |
Orchard Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$32.76 M(+207.5%) | -$66.59 M(-17.8%) |
| Jun 2023 | - | -$10.65 M(-32.7%) | -$81.03 M(-32.6%) |
| Mar 2023 | - | -$15.82 M(+115.1%) | -$120.18 M(-18.4%) |
| Dec 2022 | -$8.08 M(-94.2%) | -$7.36 M(-84.4%) | -$147.21 M(-15.7%) |
| Sep 2022 | - | -$47.20 M(-5.2%) | -$174.72 M(+6.7%) |
| Jun 2022 | - | -$49.81 M(+16.2%) | -$163.77 M(+10.1%) |
| Mar 2022 | - | -$42.85 M(+22.9%) | -$148.72 M(+7.0%) |
| Dec 2021 | -$138.93 M(-6.4%) | -$34.87 M(-3.8%) | -$138.93 M(+1.7%) |
| Sep 2021 | - | -$36.25 M(+4.3%) | -$136.58 M(+13.7%) |
| Jun 2021 | - | -$34.76 M(+5.1%) | -$120.12 M(-8.7%) |
| Mar 2021 | - | -$33.06 M(+1.7%) | -$131.63 M(-11.3%) |
| Dec 2020 | -$148.38 M | -$32.51 M(+64.4%) | -$148.38 M(-7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$19.78 M(-57.2%) | -$160.05 M(-10.1%) |
| Jun 2020 | - | -$46.27 M(-7.1%) | -$178.10 M(-2.4%) |
| Mar 2020 | - | -$49.81 M(+12.7%) | -$182.48 M(+12.3%) |
| Dec 2019 | -$162.45 M(-30.5%) | -$44.19 M(+16.8%) | -$162.45 M(+9.7%) |
| Sep 2019 | - | -$37.83 M(-25.3%) | -$148.10 M(+3.5%) |
| Jun 2019 | - | -$50.65 M(+70.1%) | -$143.06 M(-42.4%) |
| Mar 2019 | - | -$29.78 M(-0.2%) | -$248.34 M(+7.0%) |
| Dec 2018 | -$233.83 M(+512.0%) | -$29.84 M(-9.0%) | -$232.14 M(+14.8%) |
| Sep 2018 | - | -$32.78 M(-79.0%) | -$202.29 M(+19.3%) |
| Jun 2018 | - | -$155.94 M(+1049.0%) | -$169.51 M(+1149.0%) |
| Mar 2018 | - | -$13.57 M | -$13.57 M |
| Dec 2017 | -$38.21 M(+99.0%) | - | - |
| Dec 2016 | -$19.20 M | - | - |
FAQ
- What is Orchard Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Orchard Therapeutics?
- What is Orchard Therapeutics annual EBITDA year-on-year change?
- What is Orchard Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly EBITDA year-on-year change?
- What is Orchard Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Orchard Therapeutics?
- What is Orchard Therapeutics TTM EBITDA year-on-year change?
What is Orchard Therapeutics annual EBITDA?
The current annual EBITDA of ORTX is -$8.08 M
What is the all time high annual EBITDA for Orchard Therapeutics?
Orchard Therapeutics all-time high annual EBITDA is -$8.08 M
What is Orchard Therapeutics annual EBITDA year-on-year change?
Over the past year, ORTX annual EBITDA has changed by +$130.85 M (+94.18%)
What is Orchard Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ORTX is -$32.76 M
What is the all time high quarterly EBITDA for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly EBITDA is -$7.36 M
What is Orchard Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ORTX quarterly EBITDA has changed by +$14.44 M (+30.59%)
What is Orchard Therapeutics TTM EBITDA?
The current TTM EBITDA of ORTX is -$66.59 M
What is the all time high TTM EBITDA for Orchard Therapeutics?
Orchard Therapeutics all-time high TTM EBITDA is -$13.57 M
What is Orchard Therapeutics TTM EBITDA year-on-year change?
Over the past year, ORTX TTM EBITDA has changed by +$108.13 M (+61.89%)